肿瘤科

订阅

MedSci主页 / 所有栏目 / 肿瘤科

基于多组学的肺小结节良恶性鉴别诊断前瞻性多中心临床研究：直播预告

2021-04-17 网络 网络

关注

观看直播

肺癌的发病率和死亡率均处于我国恶性肿瘤首位。晚期肺癌患者的预后很差，而早期肺癌患者经过以手术为主的科学治疗预后良好。绝大多数早期肺癌表现为肺结节，因此，早期发现并识别出恶性肺结节患者，是降低肺癌死亡风险的重要预防措施。

据统计，中国人群中肺癌高危人群比例占整体人群比例 20% 以上，在肺癌高危人群中肺结节的发病率达到 35.5%，即超过1亿的中国人为肺结节患者。

肺部小结节 95% 以上都是良性结节。目前在进行小于 3cm 的肺小结节良恶性鉴别诊断时，对 LDCT 影像的临床判读经验要求较高，且缺乏形态影像信息以外的其他生物学信息补充。临床上亟需一套包含了影像和分子检测等多层次信息的肺小结节良恶性鉴别诊断解决方案。

MISSION（ Multi-omIcs claSSIfier for pulmOnary Nodules ） 计划是由上海市肺科医院等全国十数家医院共同参与，由泰莱生物牵头发起，旨在利用多组学技术(代谢组、蛋白组、表观遗传组、影像组)，针对医学影像显示肺小结节（≤3cm）的患者进行肺小结节良恶性鉴别诊断的前瞻性多中心临床研究项目。

MISSION 计划将分 2 期进行，预计共计入组 2 万例临床样本，为目前国内最大的多组学单癌种的临床鉴别诊断前瞻性多中心临床研究队列。

MISSION・基于多组学的肺小结节良恶性鉴别诊断前瞻性多中心临床研究启动仪式将在本周日4月18日 下午15:30进行线上直播。启动仪式上，上海市肺科医院副院长陈昶教授将与大家进行该研究项目的具体分享。另外，武汉大学龚健雅院士、四川大学华西医院疾病分子网络前沿中心谢丹教授等嘉宾，也将就生命健康数据的人工智能研究、多组学技术研究等领域进行分享。

点击观看本次直播

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1904062, encodeId=456a190406252, content=<a href='/topic/show?id=7d454302945' target=_blank style='color:#2F92EE;'>#多中心#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43029, encryptionId=7d454302945, topicName=多中心)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02f5179, createdName=luoxiaog, createdTime=Sat Mar 19 03:50:10 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1994367, encodeId=bb54199436e31, content=<a href='/topic/show?id=359a4e09482' target=_blank style='color:#2F92EE;'>#小结节#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47094, encryptionId=359a4e09482, topicName=小结节)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=734374, createdName=gjsgj, createdTime=Sat Dec 11 16:50:10 CST 2021, time=2021-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2006521, encodeId=b5f72006521f4, content=<a href='/topic/show?id=924a3264381' target=_blank style='color:#2F92EE;'>#前瞻性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32643, encryptionId=924a3264381, topicName=前瞻性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cb32500112, createdName=1508842480_96220437, createdTime=Tue Mar 01 03:50:10 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959572, encodeId=bc149595e200, content=<a href='/topic/show?id=a3e410423183' target=_blank style='color:#2F92EE;'>#梅斯直播#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=244, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104231, encryptionId=a3e410423183, topicName=梅斯直播)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221103/2796e00c9b4549e3b313ed9e7accc68f/b52d6d98bbe04782b5a4e2dd1ee80be2.jpeg, createdBy=078e1614372, createdName=MedSciZeng, createdTime=Thu Apr 22 20:56:36 CST 2021, time=2021-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1506963, encodeId=c58b150696342, content=<a href='/topic/show?id=a66b9624e0c' target=_blank style='color:#2F92EE;'>#鉴别诊断#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96247, encryptionId=a66b9624e0c, topicName=鉴别诊断)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77179846395, createdName=Homburg, createdTime=Mon Apr 19 08:50:10 CST 2021, time=2021-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958099, encodeId=b39b958099fe, content=好期待, beContent=null, objectType=article, channel=null, level=null, likeNumber=231, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd7e110192, createdName=zhu333, createdTime=Sun Apr 18 21:53:11 CST 2021, time=2021-04-18, status=1, ipAttribution=)]
    2022-03-19 luoxiaog

    #多中心#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1904062, encodeId=456a190406252, content=<a href='/topic/show?id=7d454302945' target=_blank style='color:#2F92EE;'>#多中心#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43029, encryptionId=7d454302945, topicName=多中心)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02f5179, createdName=luoxiaog, createdTime=Sat Mar 19 03:50:10 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1994367, encodeId=bb54199436e31, content=<a href='/topic/show?id=359a4e09482' target=_blank style='color:#2F92EE;'>#小结节#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47094, encryptionId=359a4e09482, topicName=小结节)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=734374, createdName=gjsgj, createdTime=Sat Dec 11 16:50:10 CST 2021, time=2021-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2006521, encodeId=b5f72006521f4, content=<a href='/topic/show?id=924a3264381' target=_blank style='color:#2F92EE;'>#前瞻性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32643, encryptionId=924a3264381, topicName=前瞻性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cb32500112, createdName=1508842480_96220437, createdTime=Tue Mar 01 03:50:10 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959572, encodeId=bc149595e200, content=<a href='/topic/show?id=a3e410423183' target=_blank style='color:#2F92EE;'>#梅斯直播#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=244, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104231, encryptionId=a3e410423183, topicName=梅斯直播)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221103/2796e00c9b4549e3b313ed9e7accc68f/b52d6d98bbe04782b5a4e2dd1ee80be2.jpeg, createdBy=078e1614372, createdName=MedSciZeng, createdTime=Thu Apr 22 20:56:36 CST 2021, time=2021-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1506963, encodeId=c58b150696342, content=<a href='/topic/show?id=a66b9624e0c' target=_blank style='color:#2F92EE;'>#鉴别诊断#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96247, encryptionId=a66b9624e0c, topicName=鉴别诊断)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77179846395, createdName=Homburg, createdTime=Mon Apr 19 08:50:10 CST 2021, time=2021-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958099, encodeId=b39b958099fe, content=好期待, beContent=null, objectType=article, channel=null, level=null, likeNumber=231, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd7e110192, createdName=zhu333, createdTime=Sun Apr 18 21:53:11 CST 2021, time=2021-04-18, status=1, ipAttribution=)]
    2021-12-11 gjsgj

    #小结节#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1904062, encodeId=456a190406252, content=<a href='/topic/show?id=7d454302945' target=_blank style='color:#2F92EE;'>#多中心#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43029, encryptionId=7d454302945, topicName=多中心)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02f5179, createdName=luoxiaog, createdTime=Sat Mar 19 03:50:10 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1994367, encodeId=bb54199436e31, content=<a href='/topic/show?id=359a4e09482' target=_blank style='color:#2F92EE;'>#小结节#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47094, encryptionId=359a4e09482, topicName=小结节)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=734374, createdName=gjsgj, createdTime=Sat Dec 11 16:50:10 CST 2021, time=2021-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2006521, encodeId=b5f72006521f4, content=<a href='/topic/show?id=924a3264381' target=_blank style='color:#2F92EE;'>#前瞻性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32643, encryptionId=924a3264381, topicName=前瞻性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cb32500112, createdName=1508842480_96220437, createdTime=Tue Mar 01 03:50:10 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959572, encodeId=bc149595e200, content=<a href='/topic/show?id=a3e410423183' target=_blank style='color:#2F92EE;'>#梅斯直播#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=244, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104231, encryptionId=a3e410423183, topicName=梅斯直播)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221103/2796e00c9b4549e3b313ed9e7accc68f/b52d6d98bbe04782b5a4e2dd1ee80be2.jpeg, createdBy=078e1614372, createdName=MedSciZeng, createdTime=Thu Apr 22 20:56:36 CST 2021, time=2021-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1506963, encodeId=c58b150696342, content=<a href='/topic/show?id=a66b9624e0c' target=_blank style='color:#2F92EE;'>#鉴别诊断#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96247, encryptionId=a66b9624e0c, topicName=鉴别诊断)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77179846395, createdName=Homburg, createdTime=Mon Apr 19 08:50:10 CST 2021, time=2021-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958099, encodeId=b39b958099fe, content=好期待, beContent=null, objectType=article, channel=null, level=null, likeNumber=231, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd7e110192, createdName=zhu333, createdTime=Sun Apr 18 21:53:11 CST 2021, time=2021-04-18, status=1, ipAttribution=)]
    2022-03-01 1508842480_96220437

    #前瞻性#

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1904062, encodeId=456a190406252, content=<a href='/topic/show?id=7d454302945' target=_blank style='color:#2F92EE;'>#多中心#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43029, encryptionId=7d454302945, topicName=多中心)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02f5179, createdName=luoxiaog, createdTime=Sat Mar 19 03:50:10 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1994367, encodeId=bb54199436e31, content=<a href='/topic/show?id=359a4e09482' target=_blank style='color:#2F92EE;'>#小结节#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47094, encryptionId=359a4e09482, topicName=小结节)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=734374, createdName=gjsgj, createdTime=Sat Dec 11 16:50:10 CST 2021, time=2021-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2006521, encodeId=b5f72006521f4, content=<a href='/topic/show?id=924a3264381' target=_blank style='color:#2F92EE;'>#前瞻性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32643, encryptionId=924a3264381, topicName=前瞻性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cb32500112, createdName=1508842480_96220437, createdTime=Tue Mar 01 03:50:10 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959572, encodeId=bc149595e200, content=<a href='/topic/show?id=a3e410423183' target=_blank style='color:#2F92EE;'>#梅斯直播#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=244, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104231, encryptionId=a3e410423183, topicName=梅斯直播)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221103/2796e00c9b4549e3b313ed9e7accc68f/b52d6d98bbe04782b5a4e2dd1ee80be2.jpeg, createdBy=078e1614372, createdName=MedSciZeng, createdTime=Thu Apr 22 20:56:36 CST 2021, time=2021-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1506963, encodeId=c58b150696342, content=<a href='/topic/show?id=a66b9624e0c' target=_blank style='color:#2F92EE;'>#鉴别诊断#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96247, encryptionId=a66b9624e0c, topicName=鉴别诊断)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77179846395, createdName=Homburg, createdTime=Mon Apr 19 08:50:10 CST 2021, time=2021-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958099, encodeId=b39b958099fe, content=好期待, beContent=null, objectType=article, channel=null, level=null, likeNumber=231, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd7e110192, createdName=zhu333, createdTime=Sun Apr 18 21:53:11 CST 2021, time=2021-04-18, status=1, ipAttribution=)]
    2021-04-22 MedSciZeng

    #梅斯直播#

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1904062, encodeId=456a190406252, content=<a href='/topic/show?id=7d454302945' target=_blank style='color:#2F92EE;'>#多中心#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43029, encryptionId=7d454302945, topicName=多中心)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02f5179, createdName=luoxiaog, createdTime=Sat Mar 19 03:50:10 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1994367, encodeId=bb54199436e31, content=<a href='/topic/show?id=359a4e09482' target=_blank style='color:#2F92EE;'>#小结节#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47094, encryptionId=359a4e09482, topicName=小结节)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=734374, createdName=gjsgj, createdTime=Sat Dec 11 16:50:10 CST 2021, time=2021-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2006521, encodeId=b5f72006521f4, content=<a href='/topic/show?id=924a3264381' target=_blank style='color:#2F92EE;'>#前瞻性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32643, encryptionId=924a3264381, topicName=前瞻性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cb32500112, createdName=1508842480_96220437, createdTime=Tue Mar 01 03:50:10 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959572, encodeId=bc149595e200, content=<a href='/topic/show?id=a3e410423183' target=_blank style='color:#2F92EE;'>#梅斯直播#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=244, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104231, encryptionId=a3e410423183, topicName=梅斯直播)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221103/2796e00c9b4549e3b313ed9e7accc68f/b52d6d98bbe04782b5a4e2dd1ee80be2.jpeg, createdBy=078e1614372, createdName=MedSciZeng, createdTime=Thu Apr 22 20:56:36 CST 2021, time=2021-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1506963, encodeId=c58b150696342, content=<a href='/topic/show?id=a66b9624e0c' target=_blank style='color:#2F92EE;'>#鉴别诊断#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96247, encryptionId=a66b9624e0c, topicName=鉴别诊断)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77179846395, createdName=Homburg, createdTime=Mon Apr 19 08:50:10 CST 2021, time=2021-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958099, encodeId=b39b958099fe, content=好期待, beContent=null, objectType=article, channel=null, level=null, likeNumber=231, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd7e110192, createdName=zhu333, createdTime=Sun Apr 18 21:53:11 CST 2021, time=2021-04-18, status=1, ipAttribution=)]
    2021-04-19 Homburg

    #鉴别诊断#

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1904062, encodeId=456a190406252, content=<a href='/topic/show?id=7d454302945' target=_blank style='color:#2F92EE;'>#多中心#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43029, encryptionId=7d454302945, topicName=多中心)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=02f5179, createdName=luoxiaog, createdTime=Sat Mar 19 03:50:10 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1994367, encodeId=bb54199436e31, content=<a href='/topic/show?id=359a4e09482' target=_blank style='color:#2F92EE;'>#小结节#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47094, encryptionId=359a4e09482, topicName=小结节)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=734374, createdName=gjsgj, createdTime=Sat Dec 11 16:50:10 CST 2021, time=2021-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2006521, encodeId=b5f72006521f4, content=<a href='/topic/show?id=924a3264381' target=_blank style='color:#2F92EE;'>#前瞻性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32643, encryptionId=924a3264381, topicName=前瞻性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cb32500112, createdName=1508842480_96220437, createdTime=Tue Mar 01 03:50:10 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959572, encodeId=bc149595e200, content=<a href='/topic/show?id=a3e410423183' target=_blank style='color:#2F92EE;'>#梅斯直播#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=244, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104231, encryptionId=a3e410423183, topicName=梅斯直播)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221103/2796e00c9b4549e3b313ed9e7accc68f/b52d6d98bbe04782b5a4e2dd1ee80be2.jpeg, createdBy=078e1614372, createdName=MedSciZeng, createdTime=Thu Apr 22 20:56:36 CST 2021, time=2021-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1506963, encodeId=c58b150696342, content=<a href='/topic/show?id=a66b9624e0c' target=_blank style='color:#2F92EE;'>#鉴别诊断#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96247, encryptionId=a66b9624e0c, topicName=鉴别诊断)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77179846395, createdName=Homburg, createdTime=Mon Apr 19 08:50:10 CST 2021, time=2021-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958099, encodeId=b39b958099fe, content=好期待, beContent=null, objectType=article, channel=null, level=null, likeNumber=231, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd7e110192, createdName=zhu333, createdTime=Sun Apr 18 21:53:11 CST 2021, time=2021-04-18, status=1, ipAttribution=)]
    2021-04-18 zhu333

    好期待

    0